Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 1.00 |
| ▸ | PTPN2 | P17706 | 4/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 3/20 | 1.00 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 1.00 |
| ▸ | PYGM | P11217 | 1/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.83 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.80 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.80 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.80 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.80 |
| ▸ | POLB | P06746 | 3/20 | 0.78 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.78 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.78 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.78 |
| ▸ | PTPRC | P08575 | 2/20 | 0.78 |
| ▸ | PTPRF | P10586 | 2/20 | 0.78 |
| ▸ | F3 | P13726 | 2/20 | 0.78 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.78 |
| ▸ | CES1 | P23141 | 2/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maslinic Acid SCHEMBL18420546 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL5797455 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL14132395 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL24627035 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL5797458 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL23716504 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL12638707 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL22026389 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL21296155 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM | |
| Maslinic Acid SCHEMBL570425 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2AKR1B10GPBAR1PYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114558061-A | Loquat leaf extract and preparation method and application thereof | 浙江大学 | 2022-05-31 | — | — | CN | claimed |
| CN-102573865-B | Composition for preventing and treating erythrocyte aggregation | 基因雷克斯制药有限公司 | 2016-08-24 | — | — | CN | claimed |
| CN-102497873-B | Compositions and methods for increasing life and health | GENEREX PHARMACEUTICALS, INC. (CN) | 2016-04-13 | — | — | CN | claimed |
| EP-1569668-B1 | AN ORGANIC EXTRACT OF GEUM JAPONICUM THUMB VARIANT AND USE THEREOF | LEAD BILLION LTD (CN) | 2011-07-20 | — | — | EP | claimed |
| EP-1569668-A4 | AN ORGANIC EXTRACT OF GEUM JAPONICUM THUMB VARIANT AND USE THEREOF | UNIV HONG KONG CHINESE (HK) | 2009-07-01 | — | — | EP | claimed |
| US-7387801-B2 | Organic extract of Geum japonicum Thunb variant and use thereof | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2008-06-17 | — | — | US | claimed |
| EP-1773313-A4 | CONTROL OF BIOFILM FORMATION | ELDRIDGE GARY R (US) | 2007-11-07 | — | — | EP | claimed |
| EP-1773313-A2 | CONTROL OF BIOFILM FORMATION | Eldridge, Gary R. (US) | 2007-04-18 | — | — | EP | claimed |
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | SEQUOIA SCIENCES, INC. | 2007-01-18 | — | — | US | claimed |
| US-20060264411-A1 | Control of biofilm formation | SEQUOIA SCIENCES, INC. | 2006-11-23 | — | — | US | claimed |
| US-20060134229-A1 | Organic extract of geum japonicum thunb variant and use thereof | CHINESE UNIVERSITY OF HONG KONG (CN) | 2006-06-22 | — | — | US | claimed |
| WO-2006019881-A2 | COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS AND BACTERIAL INFECTIONS | ELDRIDGE GARY R (US) | 2006-02-23 | — | — | WO | claimed |
| WO-2006010147-A2 | CONTROL OF BIOFILM FORMATION | ELDRIDGE GARY R (US) | 2006-01-26 | — | — | WO | claimed |
| EP-1569668-A1 | AN ORGANIC EXTRACT OF GEUM JAPONICUM THUMB VARIANT AND USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (HK) | 2005-09-07 | — | — | EP | claimed |
| WO-2004052381-A1 | AN ORGANIC EXTRACT OF GEUM JAPONICUM THUMB VARIANT AND USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2004-06-24 | — | — | WO | claimed |
| CN-114558061-B | Loquat leaf extract and preparation method and application thereof | 浙江大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-114558061-A | Loquat leaf extract and preparation method and application thereof | 浙江大学 | 2022-05-31 | — | — | CN | disclosed |
| WO-2004052381-A1 | AN ORGANIC EXTRACT OF GEUM JAPONICUM THUMB VARIANT AND USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2004-06-24 | — | — | WO | disclosed |
| WO-2003043645-A1 | COMPOSITIONS COMPRISING ORGANIC EXTRACTS OF GEUM JAPONICUM THUNB VAR. AND THE USE THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2003-05-30 | — | — | WO | disclosed |
| US-5916919-A | TRITERPENES | DALHOUSIE UNIVERSITY (CA) | 1999-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | RHOA, ALOX5, BLVRB | PTPN1 1158/4885PTPN2 1629/4885AKR1B10 2879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.